Alexion Pharmaceuticals Inc. (Nasdaq: ALXN) named Paul Clancy to the position of chief financial officer. Shares of the biopharmaceutical soared $10.00 to close at $118.00.
Alexion Pharmaceuticals names new CFO
June 14, 2017 at 17:55 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.